***Background.*** Though not considered common features of *Clostridium difficile* infection (CDI), patients with community-associated CDI (CA-CDI) often report nausea or vomiting. We evaluated the prevalence of co-infection with other gastrointestinal (GI) pathogens that cause nausea or vomiting and diarrhea among patients with CA-CDI to ascertain how frequently co-infection may contribute to CA-CDI illness.

***Methods.*** We enrolled CA-CDI cases (*C. difficile*-positive stool specimen collected as an outpatient or within 3 days after admission from a person aged ≥1 year who did not have a positive assay ≤8 weeks and an overnight stay in a healthcare facility ≤ 12 weeks prior to stool collection) from December 1, 2012 -- February 28, 2013 in 5 Emerging Infections Program sites participating in CDI surveillance. Demographic data, clinical data and GI bacterial pathogen testing were abstracted from medical records. *C. difficile*-positive stool specimens associated with case data were submitted for *C. difficile* culturing and RT-PCR for norovirus, rotavirus, sapovirus, astrovirus and adenovirus. Chi-square or Wilcoxon rank-sum tests were used to evaluate differences between co-infected and non-co-infected cases.

***Results.*** Of 187 CA-CDI cases enrolled, 14 (7.5%) tested positive for norovirus, 4 (2.1%) for enteric adenovirus, 3 (1.6%) for rotavirus, and 2 (1.1%) for sapovirus; one had a positive *Campylobacter* test. There were no significant differences between co-infected (n = 24) and non-co-infected cases (n = 163) with regards to age (median = 58 vs 55, *p* = 0.6), documentation of diarrhea (41% vs 45%, *p* = 0.7), nausea or vomiting (45% vs 30%, *p* = 0.1), antimicrobial exposure in the 12 weeks prior to specimen collection (41% vs 57%, *p* = 0.1), or detection of *C. difficile* by molecular assay (66% vs 61%, *p = 0.6*). Co-infected cases were less likely to be *C. difficile*-culture positive (66% vs 88%, *p* = 0.01) and to be North American Pulsed-Field type 1 (NAP1) (4% vs 20%, *p* = 0.03).

***Conclusion.*** Although lower rates of *C. difficile* isolation and the NAP1 strain suggest co-infection could be a cause of *C. difficile* pseudoinfection in the community, this appears uncommon. Based on our data, clinical characteristics alone cannot differentiate these cases.
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